Reversible pituitary hyperplasia and hypopituitarism in two cases of primary hypothyroidism;Hiperlasia y disfuncion hipofisaria reversible en dos casos de hipotiroidismo primario

Revista Clinica Espanola

Volumn 198, Issue 1, 1998, Pages 28-32

  Fernandez Real J M ^a,b   Ricart, W ^a   Porcar, C ^a   Teruel, J ^a  

^a Hospital Universitario   (Spain)

^b HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Hypopituitarism; Hypothyroidism

Indexed keywords

BROMOCRIPTINE; FOLLITROPIN; GONADORELIN; GONADOTROPIN; GROWTH HORMONE; LEVOTHYROXINE; PROLACTIN; SOMATOSTATIN; THYROTROPIN;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CELL HYPERPLASIA; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERPROLACTINEMIA; HYPOPHYSIS FUNCTION; HYPOPITUITARISM; HYPOTHYROIDISM; LUTEINIZING HORMONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; RISK ASSESSMENT; THYROTROPIN BLOOD LEVEL; ENDOCRINE FUNCTION TEST; HYPERPLASIA; HYPOPHYSIS; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; FEMALE; HUMANS; HYPERPLASIA; HYPOPITUITARISM; HYPOTHYROIDISM; MIDDLE AGED; PITUITARY FUNCTION TESTS; PITUITARY GLAND;

EID: 0031613785     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Scheithauer BW, Kovacs K, Randall RV, Ryan N. Pituitary gland in hypothyroidism Histologic and immunocytologic study. Arch Pathol Lab Med 1985, 109 499-504.
2. Yamada T, Tsukui T, Ikejiri K, Yukimura Y, Kotani M. Volume of sella turcica in normal subjects and in patients with primary hypothyroidism and hyperthyroidism. J Clin Endocrinol Metab 1976, 42:817-822.
3. Scanlon MF, Mora B, Shale DJ, Weightman DR, Heath M, Snow MH Evidence for dopaminergic control of thyrotrophin secretion in man. Lancet 1977; 2:421-423
4. Bigos ST, Ridgway C, Kourides IA, Maloof F. Spectrum of pituitary alterations with mild and severe thyroid impairment. J Clin Endocrinol Metab 1978; 46:317-325
5. LaFranchi SH, Hanna CE, Krainz PL. Primary hypothyroidism. empty sella, and hypopituitarism. J Pediatr 1986: 108:571-573
6. Smallridge RC Thyrotropin-secreting pituitary tumors Endocrinol Metab Clin North Am 1987; 765-793
7. Katevuo K, Valimäki M, Ketonen L, Lamberg BA, Pelkonen R. Computed tomography of the pituitary fossa in primary hypothyroidism. Effect of thyroxine treatment. Clin Endocrinol 1985: 22:617-621
8. Hutchins WW, Crues JV IIIrd, Miya P, Pojunas KW. MR demonstration of pituitary hyperplasia and regression after therapy for hypothyroidism. Am J Neuroradiol 1990; 11:410
9. Wolanski LJ, Leavitt GD, Elias BJ, Lee HJ, Dasmahapatra A, Byme W. MRI of pituitary hyperplasia in hypothyroidism Neuroradiology 1996; 38.50-52.
10. Sarlis NJ, Brucker-Davis F, Doppman JL, Skarulis MC. MRI-demonstrable regression of a pituitary mass in a case of primary hypothyroidism after a week of acute thyroid hormone therapy. J Clin Endocrinol Metab 1997; 82:808-811.
11. Atchison JA, Lee PA, Albright AL Reversible suprasellar pituitary mass secondary to hypothyroidism. JAMA 1989; 262-3.175-3.177.
12. Snyder PJ. The pituitary in hypothyroidism. En Braverman LE. Utíger RD. eds. The thyroid. Werner and Ingbar's, 1991.
13. Contreras P, Generini G, Michelsen H, Pumarino H, Campino C. Hyperprolactinemia and galactorrhea; spontaneous versus iatrogenic hypothyroidism. J Clin Endocrinol Metab 1981, 53:1.036-1.039
14. Cave WT Jr, Paul MA. Effects of altered thyroid function on plasma prolactin clearance Endocrinology 1980: 107:85-91
15. Refetoff S, Fang VS, Rapoport B, Friesen HG. Interrelationships in the regulation of TSH and prolactin in man: effects of L-dopa. TRH and thyroid hormone in various combinations J Clin Endocrinol Metab 1974: 38 450-457
16. Miyai K, Orushi T, Hosokawa M, Ishibashi K, Kumahara Y Inhibition of thyrotropic and prolactin secretions in primary hypothyroidism by 2-Br-α-ergocryptine J Clin Endocrinol Metab 1974, 39:391.
17. Burrow GN, May PB, Spaulding SW. Donabedian RK TRH and dopamine interactions affecting hormone secretion. J Clin Endocrinol Metab 1977, 45:65-72.
18. Valcavi R, Zini M, Diéguez C, Portioli I Vasoactive intestinal peptide-induced prolactin release in hypothyroid patients. J Endocrinol Invest 1993: 16.781-785
19. Watanabe H, Sasaki S Effect of thyroid status on the prolactin-releasing action of vasoactive intestinal peptide in humans: comparison with the action of thyrotropin-releasing hormone. Neuroendocrinology 1995; 61:207-212.
20. Hickman PE The effect of endogenous somatostatin upon human thyrotrophin (TSH) secretion Horm Metab Res 1992, 24:73-77
21. Williams T, Maxon H, Thorner MO, Frohman LA. Blunted growth hormone (GH) response to GH-releasing hormone in hypothyroidism resolves in the euthyroid state. J Clin Endocrinol Metab 1985; 61:454.
22. Iwatsubo H, Omon K, Okada Y, et al. Human growth hormone secretion in primary hypothyroidism before and after treatment J Clin Endocrinol Metab 1967, 27 1 751-1 754.
23. Brauman H, Corvilain J. Growth hormone response to hypoglycemia in myxedema. J Clin Endocrinol Metab 1968: 28:301-304.
24. Wilkinson R, Anderson M, Smart GA. Growth-hormone deficiency in iatrogenic hypothyroidism. Br Med J 1972; 2:87-88.
25. Nishi Y, Hamamoto K, Kajiyama M. et al Pituitary enlargement. hypertrichosis and blunted growth hormone secretion in primary hypothyroidism. Acta Paediatr Scand 1989; 78:136-140.
26. Vagenakis AG, Dole K, Braverman LE. Pituitary enlargement, pituitary failure, and primary hypothyroidism Ann Intern Med 1976; 85 195-198
27. Jawadi MH, Ballonof LB, Stears JC, Katz FH. Primary hypothyroidism and pituitary enlargement Radiological evidence of pituitary regression. Arch Intern Med 1978; 138.1 555-1.557.
28. Tunbridge WMG, Marshall JC, Burke CW. Primary hypothyroidism presenting as pituitary failure Br Med J 1973; 1:153-154.
29. Lawrence AM, Wilber JF, Hagen TC The pituitary and primary hypothyroidism. Enlargement and unusual growth hormone secretory responses Arch Intern Med 1973, 132:327-333
30. Ridgway EC, McCammon JA, Benotti J, Maloof F. Acute metabolic responses in myxedema to large doses of intravenous L-thyroxine. Ann Intern Med 1972; 77:549-555.
31. Lessof MH, Maisey MN, Lyne C, Sturge RA Effect of thyroid failure on the pituitary-adrenal axis Lancet 1969, 1:642-644.
32. Keye WR, Ho Yuen B, Knopf RF, Jaffe RB. Amenorrhea, hyperprolactinemia. and pituitary enlargement secondary to primary hypothyroidism Succesful treatment with thyroid replacement. Obstetr Gynecol 1976, 48:697-702
33. Iranmanesh A, Lizarralde G, Johnson ML, Veldhuis JD. Dynamics of 24-hour endogenous cortisol secretion and clearance in primary hypothyroidism assessed before and after partial thyroid hormone replacement. J Clin Endocrinol Metab 1990; 70:155-161.
34. Distiller LA, Sagel J, Morley JE. Assessment of pituitary gonadotropin reserve using luteinizing hormone-releasing hormone (LRH) in states of altered thyroid function. J Clin Endocrinol Metab 1975, 40:512-515
35. Ambrosi B, Giovine C, Nava C, Elli R, Faglia G. Serum gonadotrophin pulsatile secretion in men with prolacting-secreting and non-secreting pituitary tumours. Acta Endocrinol (Copenh) 1985; 109:1.
36. Poretsky L, Garber J, Kleefield J. Primary amenorrhea and pseudoprolactinoma in a patient with primary hypothyroidism. Reversal of clinical, biochemical, and radiologic abnormalities with levothyroxine. Am J Med 1986; 81:180-182.